News
Molecular engineers have now show that it is possible to build complex, custom-designed transmembrane proteins from scratch. In the living world, transmembrane proteins naturally occur embedded in ...
Transmembrane proteins from the House of Nature are abundant, but they’re all off the rack. Yes, they have been tailored to serve diverse functions, from transmembrane transport to cell ...
Sino Biological has three separate platforms by which to develop and manufacture multi-pass transmembrane proteins.
In this interview, Dr. Fang-Yi Chu talks to NewsMedical about the role of transmembrane proteins in targeting oncology research. Can you explain what transmembrane proteins are and why they are ...
A group of researchers at the VIB‑UGent Center for Medical Biotechnology has developed a new platform to isolate and analyze ...
Aggression is a complex behavior dependent on numerous factors such as personal experiences, upbringing, social context, personality and genetics. Florian Reichmann and his team at the Med Uni Graz ...
Transmembrane proteins play a critical role in signal transduction, cell adhesion, nutrient uptake, and immune response modulation. However, dysregulation of transmembrane proteins can contribute to ...
Transmembrane proteins (TPs) serve as crucial conduits between the internal and external environments of cells, regulating ion and molecule passage and orchestrating cellular responses to external ...
2d
AZoLifeSciences on MSNResearchers Uncover Complex Substrate Profile for Enzyme ActionResearch on γ-secretase reveals its unique substrate recognition mechanism, offering potential for developing precise ...
Researchers showed that interferon-induced transmembrane proteins (IFITMs) help medium-sized druglike molecules (right), which are too large to diffuse across the plasma membrane, to enter cells.
12d
Clinical Trials Arena on MSNChina’s NMPA approves initiation of InnoCare’s trial of B7-H3 targeted ADCIn February 2025, the NMPA approved a Phase III trial of InnoCare Pharma’s ICP-248 (Mesutoclax) with orelabrutinib as a first-line therapy for chronic lymphocytic leukaemia (CLL)/small lymphocytic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results